Patents by Inventor Laura Martin
Laura Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240150293Abstract: Compounds of Formula (I): wherein R1, R3, R11, R12, X, Y1, Y2, Y3, Y4 and are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring anti-apoptotic inhibitors.Type: ApplicationFiled: January 11, 2022Publication date: May 9, 2024Inventors: Stephen STOKES, Simon BEDFORD, l-Jen CHEN, James Edward Paul DAVIDSON, Nicholas DAVIES, Christopher John GRAHAM, Sean Martin MCKENNA, Johannes W.G. MEISSNER, James Brooke MURRAY, Rachel Jane PARSONS, Stuart RAY, Emma SANDERS, Claire Louise WALMSLEY, Paul Andrew BROUGH, András KOTSCHY, Ágnes PROSZENYÁK, Ádám SINAI, Balázs Károly BÁLINT, Márton CSÉKEI, Márton ZWILLINGER, Rita GARAMVÖLGYI, Szabolcs SIPOS, Vilibald KUN, Zoltán SZABÓ, Maïa CHANRION, Francesca ROCCHETTI, Frédéric COLLAND, Ana Leticia MARAGNO, Laura BRESSON
-
Publication number: 20240095645Abstract: A method of generating customizable goal representation is disclosed. A request from a user to view a goal representation is received. A flexible goal ontology is accessed that comprises one or more goal entities, one or more goal relationships between the goal entities, or one or more goal properties, the one or more goal properties including one or more metadata attributes relating to the one or more goal entities. A set of mapping rules is obtained that defines mappings between one or more goals. The set of mapping rules is evaluated to assemble a customized goal representation tailored to the user. The customized goal representation is updated based on a revaluation of the mapping rules affected by changes to the one or more goal entities, the one or more goal relationships, or the one or more properties.Type: ApplicationFiled: September 21, 2023Publication date: March 21, 2024Inventors: Sven Martin Andreas Elfgren, Friedrich I. Riha, Elliot Piersa Dahl, Eric Koslow, Nicole Jensen McMullin, Natasha Hede, Connie Lynn Chen, Alexa Jean Kriebel, Chije Wang'ati, JR., Megan McGowan, Ami Tushar Bhatt, Jeffrey Ryan Gurr, Tyler Kowalewski, Rahul Rangnekar, Byron Sha Yang, Jerry Wu, Ricky Rizal Zein, Romain Beauxis, Adnan Chowdhury, Priya Balasubramanian, Gilles Yvetot, Shaylan Hawthorne, Adnan Pirzada, Matthew Michael Parides, Jenna Nicole Soojin Lee, Ian William Richard, Laura Elizabeth Pearson, Christian Nguyen, Tovin Thomas, Adam Carter, David Achee, David Christopher Sally, Miranda Howitt, Vincent Yao, Seth Goldenberg, Aimee Jin Peng, William Qingdong Yan, Matthew Stephen Wysocki, Michael Ryan Shohoney, Ryan Maas, Asha Camper Singh, Leonardo Faria, Elliot Piersa Dahl
-
Patent number: 11925496Abstract: Apparatus for x-ray CT scanning of an object includes an x-ray generator 1 mounted on a first support 3 on an outer ring 4 and an x-ray detector 2 mounted on a second support 10 on an inner ring 11, and a drive mechanism arranged to rotate the outer and inner rings 4, 11. The outer and inner rings have a first common axis of rotation and the diameter of the outer ring 4 is greater than the diameter of the inner ring 11 The drive mechanism includes a gearing arrangement connecting the outer and inner rings 4,11. The gearing arrangement comprises first and second toothed rotary gears 14,16.Type: GrantFiled: November 27, 2019Date of Patent: March 12, 2024Assignee: HALLMARQ VETERINARY IMAGING LTDInventors: Nicholas Martin Bolas, Eduardo Pallas Lodeiro, Laura Moliner Martinez, Giedre Podolyak, Paul Michael Kurn, James Richard Barnett
-
Patent number: 11781160Abstract: The invention relates to methods for the production of methacrylates using methacrylate tolerant microorganisms.Type: GrantFiled: May 23, 2019Date of Patent: October 10, 2023Assignee: Mitsubishi Chemical UK LimitedInventors: Zoe Disley, Graham Ronald Eastham, David William Johnson, Laura Martins, Russel Menchavez, Luca Rossoni, Gill Stephens
-
Publication number: 20220258153Abstract: A container assembly is provided for handling a biological sample that includes a first receptacle (1) and a second receptacle (2), each one configured to receive and contain a fluid; a coupling member (6), adapted to operably couple the first receptacle and the second receptacle, so as to provide a sealed fluid passage between the first and second receptacle; at least one self-sealing dispensing valve (4), operably mounted within said fluid passage of the coupling member, adapted to allow bi-directional fluid flow at a predetermined fluid pressure, and at least one barrier member (9), operably mounted within the fluid passage of the coupling member at an output of the first receptacle, configured to prevent solids of a predetermined size to pass from the first receptacle into the second receptacle.Type: ApplicationFiled: July 17, 2020Publication date: August 18, 2022Applicant: Illinois Tool Works Inc.Inventors: Marina Caubet Canals, Laura Martin Sanchez, Montserrat Lacoma Martinez, Aliex Heribert Fortuny Cuadra
-
Patent number: 11253497Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: April 22, 2020Date of Patent: February 22, 2022Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 11065799Abstract: An apparatus includes an upper lip positioned with respect to an air flow passage. The upper lip is to direct air flow from the air flow passage around a bubble of blown film. The apparatus further includes a Venturi ring movably mounted with respect to the upper lip and adjustable in position with respect to the upper lip. The Venturi ring is to adjustably lock the bubble of blown film.Type: GrantFiled: March 23, 2018Date of Patent: July 20, 2021Assignee: BRAMPTON ENGINEERING INC.Inventors: Ralph Brink, Laura Martin, Al-Amin Aziz, Winston Lewis, Gary Hughes
-
Publication number: 20210207177Abstract: The invention relates to methods for the production of methacrylates using methacrylate tolerant microorganisms.Type: ApplicationFiled: May 23, 2019Publication date: July 8, 2021Inventors: Zoe Disley, Graham Ronald Eastham, David Wlliam Johnson, Laura Martins, Russel Menchavez, Luca Rossoni, Gill Stephens
-
Patent number: 10907156Abstract: The present invention provides, among other things, methods and compositions for the effective prophylactical or therapeutical treatment of Chronic kidney disease (CKD), particularly for the prophylactical or therapeutical treatment of the tubulointerstitial fibrosis associated to CKD, more particularly for the prophylactical or therapeutical treatment of renal fibrosis.Type: GrantFiled: August 9, 2017Date of Patent: February 2, 2021Assignee: FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIV. RAMÓN Y CAJALInventors: Laura García Bermejo, Elisa Conde Moreno, Sara Gimenez Moyano, Laura Martín Gómez
-
Publication number: 20200352891Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: April 22, 2020Publication date: November 12, 2020Applicant: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Patent number: 10733549Abstract: Techniques for managing a user's tasks based on the user's focus level. High focus time slots are identified during which the user has a high level of focus, as well as low focus time slots during which the user has a low level of focus. Tasks for completion by the user are scheduled such that the high focus time slots are allocated to tasks that require a high level of user focus, and the low focus time slots are allocated to tasks that require a low level of user focus. High focus times may be identified based on user indications and/or on biometric data describing the user's physical state. Interruption requests may also be managed based on the user's focus level. Necessary resources may be pre-loaded prior to the high focus time periods, and breaks may be automatically scheduled to maintain the user's high level of focus.Type: GrantFiled: December 15, 2015Date of Patent: August 4, 2020Assignee: LogMeIn, Inc.Inventors: Ashish V. Thapliyal, Elizabeth Thapliyal, Laura Martin, Ryan W. Kasper, Ye Zhou
-
Publication number: 20200016815Abstract: An apparatus includes an upper lip positioned with respect to an air flow passage. The upper lip is to direct air flow from the air flow passage around a bubble of blown film. The apparatus further includes a Venturi ring movably mounted with respect to the upper lip and adjustable in position with respect to the upper lip. The Venturi ring is to adjustably lock the bubble of blown film.Type: ApplicationFiled: March 23, 2018Publication date: January 16, 2020Inventors: Ralph BRINK, Laura MARTIN, Al-Amin AZIZ, Winston LEWIS, Gary HUGHES
-
Publication number: 20190365690Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: December 18, 2018Publication date: December 5, 2019Applicant: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Publication number: 20190177728Abstract: The present invention provides, among other things, methods and compositions for the effective prophylactical or therapeutical treatment of Chronic kidney disease (CKD), particularly for the prophylactical or therapeutical treatment of the tubulointerstitial fibrosis associated to CKD, more particularly for the prophylactical or therapeutical treatment of renal fibrosis.Type: ApplicationFiled: August 9, 2017Publication date: June 13, 2019Inventors: Laura GARCÍA BERMEJO, Elisa CONDE MORENO, Sara GIMENEZ MOYANO, Laura MARTIN GÓMEZ
-
Patent number: 10201515Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: August 22, 2017Date of Patent: February 12, 2019Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Publication number: 20180085332Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: August 22, 2017Publication date: March 29, 2018Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Patent number: 9907772Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: July 13, 2016Date of Patent: March 6, 2018Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 9763906Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: September 29, 2015Date of Patent: September 19, 2017Assignee: Lipopharma Therapeutics S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 9763907Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: September 29, 2015Date of Patent: September 19, 2017Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Publication number: 20170169382Abstract: Techniques for managing a user's tasks based on the user's focus level. High focus time slots are identified during which the user has a high level of focus, as well as low focus time slots during which the user has a low level of focus. Tasks for completion by the user are scheduled such that the high focus time slots are allocated to tasks that require a high level of user focus, and the low focus time slots are allocated to tasks that require a low level of user focus. High focus times may be identified based on user indications and/or on biometric data describing the user's physical state. Interruption requests may also be managed based on the user's focus level. Necessary resources may be pre-loaded prior to the high focus time periods, and breaks may be automatically scheduled to maintain the user's high level of focus.Type: ApplicationFiled: December 15, 2015Publication date: June 15, 2017Inventors: Ashish V. Thapliyal, Elizabeth Thapliyal, Laura Martin, Ryan W. Kasper, Ye Zhou